Freenome, Inc. SEC filings FRNM
Freenome, Inc. has 135 filings in SEC EDGAR's recent list, going back to Apr 16, 2024. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 15, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Oct 20, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 20, 2026 | Oct 20, 2026 |
| S-8 | Employee stock plan registration | Sep 23, 2026 | — |
| EFFECT | Filing | Aug 27, 2026 | — |
| 424B3 | Prospectus | Aug 27, 2026 | — |
| S-1 | Registration statement | Aug 18, 2026 | — |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Aug 13, 2026 | Jul 20, 2026 |
| EFFECT | Filing | Jul 29, 2026 | — |
| POS AM | Filing | Jul 28, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 27, 2026 | Jul 27, 2026 |
| POS AM | Filing | Jul 24, 2026 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jul 24, 2026 | Jul 20, 2026 |
| CERT | Filing | Jul 20, 2026 | — |
| 25-NSE | Delisting notice | Jul 20, 2026 | — |
| 8-A12B | Filing | Jul 20, 2026 | — |
| 425 | Filing | Jul 15, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jul 15, 2026 | Jul 15, 2026 |
| 10-Q | Quarterly report | Jul 15, 2026 | Jun 30, 2026 |
| 424B3 | Prospectus | Jul 9, 2026 | — |
| 425 | Filing | Jul 9, 2026 | — |
| 425 | Filing | Jul 9, 2026 | — |
| 425 | Filing | Jul 9, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 9, 2026 | Jul 9, 2026 |
| 425 | Filing | Jun 18, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2026 | Jun 18, 2026 |
| EFFECT | Filing | Jun 17, 2026 | — |
| 424B4 | Prospectus | Jun 17, 2026 | — |
| S-4/A | Filing | Jun 11, 2026 | — |
| S-4/A | Filing | Jun 11, 2026 | — |
| 425 | Filing | Jun 10, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 10, 2026 | Jun 10, 2026 |
| S-4/A | Filing | Jun 1, 2026 | — |
| 425 | Filing | May 19, 2026 | — |
| DEF 14A | Proxy statement | May 14, 2026 | Jun 10, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| PRE 14A | Preliminary proxy statement | May 5, 2026 | Jun 10, 2026 |
| S-4 | Registration for a merger or exchange | Apr 28, 2026 | — |
| 425 | Filing | Apr 13, 2026 | — |
| DRS/A | Filing | Mar 30, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 425 | Filing | Mar 2, 2026 | — |
| DRS | Filing | Jan 12, 2026 | — |
| 425 | Filing | Dec 5, 2025 | — |
| 425 | Filing | Dec 5, 2025 | — |
| 425 | Filing | Dec 5, 2025 | — |
| 425 | Filing | Dec 5, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 5, 2025 | Dec 5, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 19, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K/A |
Amended current report
Other events
|
Aug 8, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Other events
|
Jun 20, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Jun 13, 2024 | Jun 11, 2024 |
| 424B4 | Prospectus | Jun 12, 2024 | — |
| EFFECT | Filing | Jun 11, 2024 | — |
| CERT | Filing | Jun 11, 2024 | — |
| CORRESP | Letter to the SEC | Jun 10, 2024 | — |
| CORRESP | Letter to the SEC | Jun 10, 2024 | — |
| CORRESP | Letter to the SEC | Jun 10, 2024 | — |
| CORRESP | Letter to the SEC | Jun 10, 2024 | — |
| 8-A12B | Form 8-a | Jun 10, 2024 | — |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| S-1/A | Amended registration statement | Jun 7, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2024 | — |
| CORRESP | Letter to the SEC | May 21, 2024 | — |
| S-1 | Registration statement | May 21, 2024 | — |
| UPLOAD | Letter from the SEC | May 16, 2024 | — |
| DRS | Filing | Apr 16, 2024 | — |
Showing 73 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- FRNM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2017526
- Former names
- Perceptive Capital Solutions Corp (until Jul 15, 2026)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.